[1] Morgan L L. The epidemiology of glioma in adults:a "state of the science" review[J]. Neuro-oncology, 2015,17(4):623-624. [2] Ahmed R, Oborski M J, Hwang M, et al. Malignant gliomas:current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods[J]. Cancer Manag Res, 2014, 6:149-170. [3] 李连进, 佟建洲,崔敬,等.脑胶质瘤组织AKT和PTEN的测定意义[J].中华肿瘤防治杂志,2016,23(S1):24-25. [4] 李岩, 石蕊,陈建新,等.VM-26和DDP联合化疗对复发高级别脑胶质瘤的治疗体会[J].中华肿瘤防治杂志,2015,22(5):786-790. [5] Xie Q, Mittal S, Berens M E. Targeting adaptive glioblastoma:an overview of proliferation and invasion[J]. Neuro Oncol, 2014, 16(12):1575-1584. [6] Kanno H, Sato H, Yokoyama T A, et al. The VHL tumor suppressor protein regulates tumorigenicity of U87-derived glioma stem-like cells by inhibiting the JAK/STAT signaling pathway[J]. Int J Oncol, 2013, 42(3):881-886. [7] Barallon R, Bauer S R, Butler J, et al. Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues[J]. In Vitro Cell Dev Biol Anim,2010,46(9):727-732. [8] Masters, J R. Cell-line authentication:End the scandal of false cell lines[J]. Nature, 2012, 492(7428):186. [9] Dirks W G, Drexler H G. STR DNA typing of human cell lines:detection of intra-and interspecies cross-contamination[J]. Methods Mol Biol,2013,946:27-38. [10] 张文丽,孔凡虹,贺文艳,等.细胞培养实验中细胞系鉴定及质量控制重要性探讨[J]. 标记免疫分析与临床, 2017, 24(1):84-87. [11] Masters, J R. Cell-line authentication:End the scandal of false cell lines[J]. Nature, 2012, 492(7428):186. [12] Lazebnik Y. What are the hallmarks of cancer?[J]. Nat Rev Cancer, 2010, 10(4):232-233. [13] Hanahan D, Weinberg R A. Hallmarks of cancer:the next generation[J]. Cell, 2011,144(5):646-674. [14] 王维娜,梁月勉,赵春兰.多灶性脑胶质瘤伴肺转移一例报告[J].中华肿瘤防治杂志,2015,22(4):312-314. |